BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 18710982)

  • 1. Apparent diffusion coefficient: potential imaging biomarker for prediction and early detection of response to chemotherapy in hepatic metastases.
    Cui Y; Zhang XP; Sun YS; Tang L; Shen L
    Radiology; 2008 Sep; 248(3):894-900. PubMed ID: 18710982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting response of colorectal hepatic metastasis: value of pretreatment apparent diffusion coefficients.
    Koh DM; Scurr E; Collins D; Kanber B; Norman A; Leach MO; Husband JE
    AJR Am J Roentgenol; 2007 Apr; 188(4):1001-8. PubMed ID: 17377036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apparent diffusion coefficient measurements as very early predictive markers of response to chemotherapy in hepatic metastasis: a preliminary investigation of reproducibility and diagnostic value.
    Deckers F; De Foer B; Van Mieghem F; Botelberge T; Weytjens R; Padhani A; Pouillon M
    J Magn Reson Imaging; 2014 Aug; 40(2):448-56. PubMed ID: 24924334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-small cell lung cancer: detection of early response to chemotherapy by using contrast-enhanced dynamic and diffusion-weighted MR imaging.
    Yabuuchi H; Hatakenaka M; Takayama K; Matsuo Y; Sunami S; Kamitani T; Jinnouchi M; Sakai S; Nakanishi Y; Honda H
    Radiology; 2011 Nov; 261(2):598-604. PubMed ID: 21852569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Locally advanced rectal carcinoma treated with preoperative chemotherapy and radiation therapy: preliminary analysis of diffusion-weighted MR imaging for early detection of tumor histopathologic downstaging.
    Sun YS; Zhang XP; Tang L; Ji JF; Gu J; Cai Y; Zhang XY
    Radiology; 2010 Jan; 254(1):170-8. PubMed ID: 20019139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early detection of therapeutic response to hepatic arterial infusion chemotherapy of liver metastases from colorectal cancer using diffusion-weighted MR imaging.
    Marugami N; Tanaka T; Kitano S; Hirohashi S; Nishiofuku H; Takahashi A; Sakaguchi H; Matsuoka M; Otsuji T; Takahama J; Higashiura W; Kichikawa K
    Cardiovasc Intervent Radiol; 2009 Jul; 32(4):638-46. PubMed ID: 19238482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ocular adnexal lymphoma: diffusion-weighted mr imaging for differential diagnosis and therapeutic monitoring.
    Politi LS; Forghani R; Godi C; Resti AG; Ponzoni M; Bianchi S; Iadanza A; Ambrosi A; Falini A; Ferreri AJ; Curtin HD; Scotti G
    Radiology; 2010 Aug; 256(2):565-74. PubMed ID: 20656841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive value of apparent diffusion coefficient in evaluation of colorectal carcinoma hepatic metastases' response to radiofrequency ablation.
    Szurowska E; Nowicki TK; Izycka-Swieszewska E; Zadrozny D; Markiet K; Studniarek M
    J Magn Reson Imaging; 2013 Nov; 38(5):1027-32. PubMed ID: 23526807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of magnetic resonance diffusion-weighted imaging in evaluating response after chemoembolization of hepatocellular carcinoma.
    Yuan Z; Ye XD; Dong S; Xu LC; Xu XY; Liu SY; Xiao XS
    Eur J Radiol; 2010 Jul; 75(1):e9-14. PubMed ID: 19540083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Colorectal liver metastases: contrast agent diffusion coefficient for quantification of contrast enhancement heterogeneity at MR imaging.
    Jia G; O'Dell C; Heverhagen JT; Yang X; Liang J; Jacko RV; Sammet S; Pellas T; Cole P; Knopp MV
    Radiology; 2008 Sep; 248(3):901-9. PubMed ID: 18710983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Malignant hepatic tumors: short-term reproducibility of apparent diffusion coefficients with breath-hold and respiratory-triggered diffusion-weighted MR imaging.
    Kim SY; Lee SS; Byun JH; Park SH; Kim JK; Park B; Kim N; Lee MG
    Radiology; 2010 Jun; 255(3):815-23. PubMed ID: 20501719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gastrointestinal stromal tumors treated with imatinib mesylate: apparent diffusion coefficient in the evaluation of therapy response in patients.
    Tang L; Zhang XP; Sun YS; Shen L; Li J; Qi LP; Cui Y
    Radiology; 2011 Mar; 258(3):729-38. PubMed ID: 21193597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diffusion-weighted imaging in predicting and monitoring the response of uterine cervical cancer to combined chemoradiation.
    Liu Y; Bai R; Sun H; Liu H; Zhao X; Li Y
    Clin Radiol; 2009 Nov; 64(11):1067-74. PubMed ID: 19822239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rectal cancer: assessment of complete response to preoperative combined radiation therapy with chemotherapy--conventional MR volumetry versus diffusion-weighted MR imaging.
    Curvo-Semedo L; Lambregts DM; Maas M; Thywissen T; Mehsen RT; Lammering G; Beets GL; Caseiro-Alves F; Beets-Tan RG
    Radiology; 2011 Sep; 260(3):734-43. PubMed ID: 21673229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of treatment response of chemoembolization in hepatocellular carcinoma with diffusion-weighted imaging on 3.0-T MR imaging.
    Sahin H; Harman M; Cinar C; Bozkaya H; Parildar M; Elmas N
    J Vasc Interv Radiol; 2012 Feb; 23(2):241-7. PubMed ID: 22019180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Focal liver lesion detection and characterization with diffusion-weighted MR imaging: comparison with standard breath-hold T2-weighted imaging.
    Parikh T; Drew SJ; Lee VS; Wong S; Hecht EM; Babb JS; Taouli B
    Radiology; 2008 Mar; 246(3):812-22. PubMed ID: 18223123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Water mobility of diffusion MRI in prediction of response to chemoembolization in liver cancer].
    Yuan Z; Ye XD; Dong S; Xu LC; Sun ZC; Xiao XS
    Zhonghua Zhong Liu Za Zhi; 2009 Apr; 31(4):293-7. PubMed ID: 19615287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early evaluation of cancer response by a new functional biomarker: apparent diffusion coefficient.
    Sun YS; Cui Y; Tang L; Qi LP; Wang N; Zhang XY; Cao K; Zhang XP
    AJR Am J Roentgenol; 2011 Jul; 197(1):W23-9. PubMed ID: 21700991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of residual breast carcinoma following neoadjuvant chemotherapy: diffusion-weighted imaging--comparison with contrast-enhanced MR imaging and pathologic findings.
    Woodhams R; Kakita S; Hata H; Iwabuchi K; Kuranami M; Gautam S; Hatabu H; Kan S; Mountford C
    Radiology; 2010 Feb; 254(2):357-66. PubMed ID: 20093508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diffusion-weighted magnetic resonance imaging in monitoring rectal cancer response to neoadjuvant chemoradiotherapy.
    Barbaro B; Vitale R; Valentini V; Illuminati S; Vecchio FM; Rizzo G; Gambacorta MA; Coco C; Crucitti A; Persiani R; Sofo L; Bonomo L
    Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):594-9. PubMed ID: 22099033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.